Latest period
$32.89M
YoY change
+28.6%
5Y CAGR
—
Peak year (2023)
$158.30M
Latest annual
$33.55M
Total Liabilities history chart for Alto Neuroscience (ANRO) from 2021 to 2025
Latest: $33.55M
Total Liabilities growth chart for Alto Neuroscience (ANRO) from 2021 to 2025
Latest: +28.6%
Total Liabilities history table for Alto Neuroscience (ANRO) from 2021 to 2025
| 2025 | $33.55M | +28.6% | +$7.46M | ||
| 2024 | $26.08M | -83.5% | −$132.22M | ||
| 2023 | $158.30M | +77.3% | +$69.04M | ||
| 2022 | $89.26M | +116.3% | +$47.99M | ||
| 2021 | $41.27M | — | — |
- 2025$33.55M+28.6%
- 2024$26.08M-83.5%
- 2023$158.30M+77.3%
- 2022$89.26M+116.3%
- 2021$41.27M—
Total Liabilities values are taken from Alto Neuroscience's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Liabilities at Alto Neuroscience (ANRO)
According to Alto Neuroscience's latest reported financial statements, the company's latest reported total liabilities is $32.89M. Total liabilities sum everything the company owes at the end of each reporting period — accounts payable, accrued expenses, debt, lease obligations, and other claims — as filed on the balance sheet. Compare with total assets and total equity for solvency context.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Alto Neuroscience (ANRO) most recent annual total liabilities stands at $33.55M (2025) – grew 28.6% year-over-year.
Across the available history, total liabilities reached its high of $158.30M in 2023 and its low of $26.08M in 2024.
Alto Neuroscience Total Liabilities by Year
Alto Neuroscience Total Liabilities 2025: $33.55M
Alto Neuroscience total liabilities in 2025 was $33.55M, grew 28.6% from 2024.
Alto Neuroscience Total Liabilities 2024: $26.08M
2024's total liabilities for Alto Neuroscience came in at $26.08M, plunged 83.5% below 2023. This figure represents the lowest annual value in the available history.
Alto Neuroscience Total Liabilities 2023: $158.30M
Alto Neuroscience posted total liabilities of $158.30M in 2023, surged 77.3% from 2022. This figure represents the highest annual value in the available history.
Alto Neuroscience Total Liabilities 2022: $89.26M
In 2022, Alto Neuroscience reported total liabilities of $89.26M, surged 116.3% from 2021.
Alto Neuroscience Total Liabilities 2021: $41.27M
Alto Neuroscience total liabilities in 2021 was $41.27M.
See more financial history for Alto Neuroscience (ANRO).
Sector peers by Total Liabilities
Healthcare peers of Alto Neuroscience (ANRO), ranked by their latest total liabilities
| $207.88B | |
| $137.19B | |
| $117.67B | |
| $85.94B | |
| $84.20B | |
| $81.93B | |
| $65.36B | |
| $54.86B |
- $207.88B
- $137.19B
- $117.67B
- $85.94B
- $84.20B
- $81.93B
- $65.36B
- $54.86B
Frequently asked questions
Alto Neuroscience (ANRO) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation